Cargando…
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
Rationale: Bedaquiline and delamanid offer the possibility of more effective and less toxic treatment for multidrug-resistant (MDR) tuberculosis (TB). With this treatment, however, some patients remain at high risk for an unfavorable treatment outcome. The endTB Observational Study is the largest mu...
Autores principales: | Franke, Molly F., Khan, Palwasha, Hewison, Cathy, Khan, Uzma, Huerga, Helena, Seung, Kwonjune J., Rich, Michael L., Zarli, Khin, Samieva, Nazgul, Oyewusi, Lawrence, Nair, Parvati, Mudassar, Mishaz, Melikyan, Nara, Lenggogeni, Putri, Lecca, Leonid, Kumsa, Andargachew, Khan, Munira, Islam, Shirajul, Hussein, Kerow, Docteur, Wisny, Chumburidze, Nino, Berikova, Elmira, Atshemyan, Hakob, Atwood, Sidney, Alam, Manzurul, Ahmed, Saman, Bastard, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781121/ https://www.ncbi.nlm.nih.gov/pubmed/32706644 http://dx.doi.org/10.1164/rccm.202001-0135OC |
Ejemplares similares
-
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the
endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022) -
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019) -
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs( )
por: Huerga, Helena, et al.
Publicado: (2022) -
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective
por: Rodriguez, Carly A., et al.
Publicado: (2023) -
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
por: Rodriguez, Carly A., et al.
Publicado: (2022)